An embryonic stem cell line created from a woman with type 1 diabetes as seen in this undated handout image provided by Bjarki Johannesson of the New York Stem Cell Foundation (NYSCF) is a perfect genetic match for her: the stem cells were induced to turn into insulin-making beta cells, which are defective in type-1 diabetes, fueling hopes that they can be implanted and cure the disease. REUTERS/Bjarki Johannesson, NYSCF/Handout via Reuters (UNITED STATES - Tags: SCIENCE TECHNOLOGY) ATTENTION EDITORS - NO SALES. NO ARCHIVES. FOR EDITORIAL USE ONLY. NOT FOR SALE FOR MARKETING OR ADVERTISING CAMPAIGNS. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. IT IS DISTRIBUTED, EXACTLY AS RECEIVED BY REUTERS, AS A SERVICE TO CLIENTS